Estrella Immunopharma, Inc. (ESLA) AI Dilution Summary
Updated Oct 7, 2026
Cash was $146,670 at 2026-06-30 against estimated monthly burn of $593,579. After that date, two option exercises raised $81,500 net on 2026-08-18 and $81,500 net on 2026-08-25. Separately, $54,999 in accrued consulting fees was payable on 2026-08-31.